DRUG · COUNSELLING NOTES
Pasireotide (intramuscular)
SIGNIFOR LAR
Updated
New prescription
indication: _____. IM q4wk by HCP; monitor glucose; warned on allergies; serious/common AEs: hyperglycemia, bradycardia, gallstones, diarrhea; non-pharm: low-sugar diet, exercise
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IM q4wk by HCP; monitor glucose; warned on allergies; serious/common AEs: hyperglycemia, bradycardia, gallstones, diarrhea; non-pharm: low-sugar diet, exercise